This compound is primarily utilized in the field of medicinal chemistry and pharmacology as a key intermediate in the synthesis of various biologically active molecules. It is particularly significant in the development of compounds targeting neurological disorders, such as depression, anxiety, and schizophrenia, due to its structural similarity to molecules that interact with neurotransmitter receptors in the brain. Additionally, it has been explored for its potential in creating novel therapeutic agents that modulate specific enzyme activities, offering promising avenues for drug discovery and development. Its unique spirocyclic structure contributes to its ability to interact with complex biological targets, making it a valuable scaffold in the design of new pharmaceuticals.